IPAR vs NBIX · P/E 17, rev $1.32B vs P/E 45, rev $2.36B
Inter Parfums Inc (IPAR) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Inter Parfums Inc (IPAR) is a household & personal products company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported IPAR revenue for 2023-12-31 was $1.32B. Net income was $187.8M. Revenue was up 21.3% from 2022-12-31 to 2023-12-31. IPAR currently screens at market cap $2.92B and trailing P/E 17.3.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
IPAR currently screens at market cap $2.92B and trailing P/E 17.3. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the IPAR and NBIX stock pages for the full models.
Not investment advice.